Introducing Chromassette®, a modular chromatography platform enabling next-generation bioprocess purification.

We will introduce Chromassette® and an application example of an integrated rapid single pass process from harvest to purified bulk, a concept demonstrated by AbbVie. Chromassette is a stackable, single-use and pre-packed chromatography cassette with a supported bed, addressing the current key challenges in manufacturing. Chromassette enhances the separation capabilities of chromatography resins and combines it with the convenience of a modular cassette.
 
Presented by Ping Huang, Director, Head of DS BioProcesses, OED, Abbvie at Redwood
Ping is Head of Drug Substance biologic processes for Oncology Early Development in Abbvie. He obtained Ph.D in Biochemical Engineering from the University of Maryland Baltimore County in 1992. After post Doc in NC State, he joined Protein Design Lab which was later acquired by Abbvie. In the last 23 years, he led teams of scientists and engineers in bioprocess dev, tech transfer and scale-up. He worked on projects in at least 30 INDs, two of them successfully progressed to BLA and FDA approvals in 2015 and 2016.
 
 
 
Sponsored by JSR Life Sciences

 
Presented by Masayoshi Nagaya, Sr. Global Technology Manager at JSR Micro Inc
Masa Nagaya has more than a decade of experience in CMC operations of bulk drug substance and drug products, product management of membrane and chromatography resin technologies, and process engineering of advanced semiconductor nanolithography materials. Today he leads JSR’s global SSG team in applications and process development for purification and recovery technologies for the biopharmaceutical industry.  He received a bachelor’s in Chemical Engineering from Bucknell University and is the author of several technical publications.